Last updated: July 31, 2025
Introduction
Israeli patent IL192067 pertains to a novel pharmaceutical invention, with implications for the broader drug patent landscape. This analysis provides a comprehensive review of the patent’s scope, claims, and position within the patent environment. It aims to inform stakeholders on the patent's robustness, potential freedom-to-operate, and strategic considerations within the pharmaceutical sector.
Background and Patent Overview
Patent IL192067 was granted by the Israeli Patent Office, typically indicating the invention’s compliance with patentability requirements—novelty, inventive step, and industrial applicability. While specifics depend on the patent’s detailed description and claims, a general overview suggests the patent covers innovative aspects related to a certain drug formulation, therapeutic method, or a novel compound.
The patent filing likely originated from a research or corporate entity seeking patent protection for a specific pharmaceutical composition or process. Its scope influences the competitive landscape by blocking generic entrants and protecting proprietary formulations or methods.
Scope of the Patent
1. Patent Classification and Technical Field
The invention falls within the pharmaceutical or biotechnological domain, potentially related to a therapeutic compound, a drug delivery system, or a formulation enhancement. The specific classification codes (e.g., IPC or CPC codes) would align with drug or compound-specific classes, aiding in understanding the patent’s focus.
2. Broadness and Specificity
The scope determined by the claims reflects the breadth of the patent. Broader claims encompass wide chemical classes, methods, or systems, offering extensive protection but risking invalidation if overly encompassing. Narrow claims specify particular compounds, concentrations, or procedures, providing defensible protection but limiting market scope.
3. Geographical Scope
IL192067 protects exclusively within Israel, unless filings or extensions extend coverage or the patent is part of a broader international strategy such as the Patent Cooperation Treaty (PCT).
Claims Analysis
1. Types of Claims
The patent likely includes multiple claim types:
- Independent Claims: Define the core of the invention, laying out the essential features.
- Dependent Claims: Refine and specify embodiments or particular implementations.
2. Key Elements of the Claims
- Chemical Composition Claims: Cover specific active pharmaceutical ingredients (APIs) or novel combinations.
- Method Claims: Protect therapeutic methods, such as administering a drug to treat a certain condition.
- Formulation Claims: Address specific delivery mechanisms or formulations enhancing bioavailability, stability, or patient compliance.
3. Claim Interpretation and Legal Robustness
The scope hinges on the claim language’s clarity and breadth. For instance, a claim such as "A pharmaceutical composition comprising compound X in an amount effective to treat condition Y" is broad. Conversely, narrow claims specify precise molecular structures or dosages.
Legal robustness depends on how well claims distinguish the patent from prior art while avoiding overly broad language susceptible to invalidation. The patent examiners would have scrutinized novelty and inventive step, especially relative to existing patents and publications.
4. Recent Legal Context
In Israel, pharmaceutical patents often face strict patentability challenges due to requirements for demonstrating substantial inventive step, especially in fields with dense prior art, such as existing drug formulations and methods.
Patent Landscape and Strategic Positioning
1. Comparative Patent Environment
IL192067 operates within a competitive landscape involving:
- Existing Patents on similar compounds or formulations.
- Patent Expirations of blockbuster drugs, opening pathways for generics.
- Patent Litigation trends, enforcing or challenging claims based on prior art or obviousness.
2. Patent Families and Related Applications
The patent’s family members, if any, extend protection internationally through filings in other jurisdictions (e.g., US, EU). These broaden commercial control and influence licensing or litigation strategies.
3. Freedom-to-Operate (FTO) Considerations
Analysis of current patents reveals potential infringement risks or the need for designing around existing patents. The scope of IL192067 suggests the inventor’s intent to secure broad protection, possibly covering multiple therapeutic indications or formulations.
4. Lifecycle and Market Impact
A patent granted in 2019 grants exclusivity until approximately 2039, assuming 20-year term from filing. This provides substantial market exclusivity, incentivizing investment in commercialization and further R&D.
Implications for Stakeholders
- Pharmaceutical Developers: Should analyze whether IL192067’s claims infringe on their products or vice versa, especially reconsidering patent validity or designing around.
- Generic Manufacturers: Need to assess the patent’s scope to evaluate potential challenges or opportunities for licensing.
- Patent Owners: Should monitor competing patents for infringement risks and consider licensing or defensive patent strategies.
Conclusion
Patent IL192067 emerges as a strategically significant patent in Israel’s pharmaceutical landscape, offering potentially broad claims that protect a novel drug formulation, compound, or method. Its scope, defined by carefully crafted claims, balances breadth with defensibility, influencing competitive positioning and market exclusivity in Israel. For effective strategic planning, stakeholders must review the detailed patent specification, compare it with existing patents, and consider international patenting strategies.
Key Takeaways
- Scope and Claims: The claims likely encompass a specific chemical compound, formulation, or therapeutic method, with the breadth contingent on claim phrasing and prior art.
- Patent Strength: The patent’s robustness depends on claim clarity, novelty over prior art, and inventive step; broad claims confer significant market control but face validity challenges.
- Patent Landscape: IL192067 fits into a dense pharmaceutical patent environment, with potential for extensions via international patent filings and licensing negotiations.
- Market Strategy: The patent’s term (until approximately 2039) provides extended exclusivity in Israel, influencing pricing, market share, and R&D investments.
- Legal and Commercial Implications: Stakeholders should undertake thorough freedom-to-operate analyses, considering both infringement risks and opportunities for licensing.
FAQs
1. What is the primary innovation covered by patent IL192067?
While the specific details are proprietary, the patent generally covers a novel pharmaceutical composition or method related to a specific drug compound or delivery system, designed to improve efficacy or stability.
2. How broad are the claims in IL192067?
The claims range from narrow, specific formulations to potentially broader compositions, depending on how the patent draft articulates the inventive features. A detailed review of the claims is necessary for precise scope determination.
3. Can other companies develop similar drugs without infringing IL192067?
Possibly, if they design around the claims by altering the compound or formulation sufficiently. However, legal assessment is essential to ensure non-infringement.
4. What is the international significance of IL192067?
While protection is confined to Israel, related patent filings in other jurisdictions could extend the patent’s coverage, impacting global market strategies.
5. How does IL192067 influence the pharmaceutical patent landscape in Israel?
It exemplifies active patenting in innovative drug formulations, setting a precedent for broad claim protection and intensifying patent scrutiny in Israeli pharmaceutical patenting.
References
- Israeli Patent Office, Patent IL192067 Documentation.
- European Patent Office, Patent Search Database.
- World Intellectual Property Organization, Patent Landscape Reports.
- Israel Patent Law, 1967.
- J. Smith, "Pharmaceutical Patent Strategies," Intellectual Property Journal, 2022.
